New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

1

Companies Land Funds to Advance Pipelines 

2021 is shaping up to be another banner year for biotech companies. According to BioSpace, funds appear to be in near-endless supply as companies advance next-gen technologies and therapeutics for the health of all. BioSpace reviews a few raking in cash for their programs.

3

AbbVie Subsidiary Scoops Up Soliton

AbbVie Inc.’s Allergan Aesthetics announced the acquisition of Soliton Inc. in a definitive agreement that is valued at $550 million. Allergan Aesthetics will pay $22.60 per share for each outstanding Soliton share.

7

New antibody drug helps patients breathe; virus may insert genetic fragments into genetic code

In a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, researchers found when a new monoclonal antibody drug was added to treatments being given to hospitalized Covid-19 patients who were still breathing on their own, Humanigen Inc.’s lenzilumab significantly improved their odds of not needing invasive mechanical ventilation.

10

CDC Updates Guidance on Covid-19 Airborne Transmission

The Centers for Disease Control and Prevention (CDC) published updated guidance communicating to the public that the coronavirus disease 2019 is an airborne threat, explicitly stating that transmission and subsequent infection with the novel coronavirus can occur via inhalation of very fine respiratory droplets as well as aerosolized particles.